The Role of Low Dose Aspirin in the Secondary Prevention of Cardiovascular Disease
This article discusses the evidence for and role of aspirin in the secondary prevention of cardiovascular events following the clinical manifestation of atherosclerotic disease.
Written by Prof Christopher Reid MSc PhD FESC and Dr Adeleh Shirangi MPH PhD
Prof Christopher Reid is a cardiovascular epidemiologist with a PhD in Epidemiology and Preventive Medicine. He is currently Professor and Principal Research Fellow in the Schools of Public Health at Monash and Curtin Universities. He currently holds a NHMRC Principal Research Fellowship and is CIA on an NHMRC Program Grant on Cardio-renal Disease and CIA of the NHMRC Centre for Research Excellence in Cardiovascular Outcomes Improvement.
Dr Adeleh Shirangi is a public health scientist and senior epidemiologist. She holds an adjunct senior lecturer position at Sir Walter School of Public Policy & International Affairs, Murdoch University and an honorary fellow at Telethon Kids Institute. Formerly, a NHMRC Sidney Sax overseas public health research fellow, postdoctoral research fellow at Imperial College of London, a UWA adjunct senior lecturer and assistant professor at School of Public Health, University of Western Australia.